DK82191A - Behandling af myelosuppression i forbindelse med erhvervet immundefekt - Google Patents

Behandling af myelosuppression i forbindelse med erhvervet immundefekt Download PDF

Info

Publication number
DK82191A
DK82191A DK082191A DK82191A DK82191A DK 82191 A DK82191 A DK 82191A DK 082191 A DK082191 A DK 082191A DK 82191 A DK82191 A DK 82191A DK 82191 A DK82191 A DK 82191A
Authority
DK
Denmark
Prior art keywords
immundefect
myelosuppression
acquired
treatment
connection
Prior art date
Application number
DK082191A
Other languages
English (en)
Other versions
DK82191D0 (da
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK82191D0 publication Critical patent/DK82191D0/da
Publication of DK82191A publication Critical patent/DK82191A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK082191A 1988-11-09 1991-05-03 Behandling af myelosuppression i forbindelse med erhvervet immundefekt DK82191A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26927688A 1988-11-09 1988-11-09
PCT/US1989/004872 WO1990004973A1 (en) 1988-11-09 1989-11-07 Treatment of myelosuppression associated with acquired immune deficiency

Publications (2)

Publication Number Publication Date
DK82191D0 DK82191D0 (da) 1991-05-03
DK82191A true DK82191A (da) 1991-05-03

Family

ID=23026570

Family Applications (1)

Application Number Title Priority Date Filing Date
DK082191A DK82191A (da) 1988-11-09 1991-05-03 Behandling af myelosuppression i forbindelse med erhvervet immundefekt

Country Status (11)

Country Link
EP (2) EP0446230A1 (da)
JP (1) JPH0651639B2 (da)
KR (1) KR960014097B1 (da)
AU (1) AU630637B2 (da)
CA (1) CA2002413A1 (da)
DK (1) DK82191A (da)
IL (1) IL92234A (da)
MY (1) MY105868A (da)
NZ (1) NZ231304A (da)
WO (1) WO1990004973A1 (da)
ZA (1) ZA898478B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3945393A (en) * 1992-04-14 1993-11-18 Schering Corporation Treatment of hepatitis with GM-CSF
EP0791061A4 (en) * 1994-03-04 1998-07-15 Ludwig Inst Cancer Res TARGET GENE BREAKING ANIMALS
US5585355A (en) * 1994-04-22 1996-12-17 Alkermes, Inc. Method for increasing blood-ocular barrier permeability with permeabilizer peptides
DE19802375A1 (de) * 1998-01-22 1999-07-29 Schenk Filterbau Gmbh Verfahren zur Entfernung und/oder Inaktivierung von Viren
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764742B2 (ja) * 1985-11-27 1995-07-12 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド Ａｉｄｓ型疾患治療用組成物
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations

Also Published As

Publication number Publication date
DK82191D0 (da) 1991-05-03
JPH0651639B2 (ja) 1994-07-06
MY105868A (en) 1995-02-28
EP0446230A1 (en) 1991-09-18
CA2002413A1 (en) 1990-05-09
IL92234A (en) 1993-06-10
AU4526889A (en) 1990-05-28
EP0370656A1 (en) 1990-05-30
JPH04500210A (ja) 1992-01-16
AU630637B2 (en) 1992-11-05
KR960014097B1 (ko) 1996-10-14
ZA898478B (en) 1990-07-25
WO1990004973A1 (en) 1990-05-17
IL92234A0 (en) 1990-07-26
KR900701301A (ko) 1990-12-01
NZ231304A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
DK70588D0 (da) Flerdelt implanterbart laegemiddelpraeparat med langtidsvirkning
DK90089D0 (da) Hudbehandlingspraeparat
DK487587D0 (da) Fluor- og calsiummidler med forsinket frigivelse
DK254488D0 (da) Azaindol- og indolizinderivater
DK82191A (da) Behandling af myelosuppression i forbindelse med erhvervet immundefekt
DK141090D0 (da) Fremstilling af human prourokinase
DK462189A (da) Skab med udleveringsmiddel
DK651188A (da) Disulfidholdige pro-laegemidler med antitumorvirkning
DK330889A (da) Annellerede indolketoner med en imidazolylalkylsubstituent
FI883704L (fi) Uni- ja rentoutusapuväline
FR2641197B1 (fr) Billard
DK41585D0 (da) Udtrykkelse af human alfa-1-antitrypsin i gaer
DK289887A (da) Anvendelse af avaron- og avarolderivater
DK289987D0 (da) Anvendelse af avaron- og avarolderivater
DK692087A (da) Peptid med renin-inhibitorisk virkning
DK124390D0 (da) Prostaglandinderivater med antitrombotisk virkning
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
SE8800424D0 (sv) Temporer tandersettning vid rotbehandlingsfall
SE8800044D0 (sv) Hoj- och senkbar badplatta
SE8800751D0 (sv) Hoj- och senkbar badplatta
DK179288A (da) Dioxolan- og dioxanderivater
GB8829080D0 (en) Improvements in showers and baths
KR900002501U (ko) 등때밀이 목욕용구
BR6600405U (pt) Disposicao construtiva introduzida em ligamento artificial
BR8803476A (pt) Aperfeicoamento em protese peniana

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment